Posted in Bone health
Posted by Geoff Beaty on 7 August 2021
Women who have premature (early) menopause or decreased oestrogen production due to cancer therapy (i.e. women taking hormonal therapy, such as aromatase inhibitors or leuprolide, or menopause induced by surgery, chemotherapy, or radiation) are at the higher risk of osteoporosis. Of note, tamoxifen increases the risk of osteoporosis in premenopausal women, but can actually increase bone density in menopausal women, thereby decreasing the chance of osteoporosis. Treatment with some chemo...
|Posted in:NewsNutritional SupplementsPrevention & RecoveryCancerBone health|